These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27311915)

  • 1. Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01).
    Rosati A; Ilvento L; L'Erario M; De Masi S; Biggeri A; Fabbro G; Bianchi R; Stoppa F; Fusco L; Pulitanò S; Battaglia D; Pettenazzo A; Sartori S; Biban P; Fontana E; Cesaroni E; Mora D; Costa P; Meleleo R; Vittorini R; Conio A; Wolfler A; Mastrangelo M; Mondardini MC; Franzoni E; McGreevy KS; Di Simone L; Pugi A; Mirabile L; Vigevano F; Guerrini R
    BMJ Open; 2016 Jun; 6(6):e011565. PubMed ID: 27311915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation.
    Ilvento L; Rosati A; Marini C; L'Erario M; Mirabile L; Guerrini R
    Epilepsy Behav; 2015 Aug; 49():343-6. PubMed ID: 26189786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KETASER01 protocol: What went right and what went wrong.
    Rosati A; L'Erario M; Bianchi R; Olivotto S; Battaglia DI; Darra F; Biban P; Biggeri A; Catelan D; Danieli G; Mondardini MC; Cordelli DM; Amigoni A; Cesaroni E; Conio A; Costa P; Lombardini M; Meleleo R; Pugi A; Tornaboni EE; Santarone ME; Vittorini R; Sartori S; Marini C; Vigevano F; Mastrangelo M; Pulitanò SM; Izzo F; Fusco L
    Epilepsia Open; 2022 Sep; 7(3):532-540. PubMed ID: 35833327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ketamine in refractory status epilepticus in children.
    Rosati A; L'Erario M; Ilvento L; Cecchi C; Pisano T; Mirabile L; Guerrini R
    Neurology; 2012 Dec; 79(24):2355-8. PubMed ID: 23197747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.
    Lyttle MD; Gamble C; Messahel S; Hickey H; Iyer A; Woolfall K; Humphreys A; Bacon NEA; Roper L; Babl FE; Dalziel SR; Ryan M; Appleton RE;
    Trials; 2017 Jun; 18(1):283. PubMed ID: 28629473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous ketamine in status epilepticus.
    Höfler J; Trinka E
    Epilepsia; 2018 Oct; 59 Suppl 2():198-206. PubMed ID: 30146731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admissions to paediatric intensive care units (PICU) with refractory convulsive status epilepticus (RCSE): A two-year multi-centre study.
    Tully I; Draper ES; Lamming CR; Mattison D; Thomas C; Martland T; Appleton R
    Seizure; 2015 Jul; 29():153-61. PubMed ID: 26076860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus.
    Gaínza-Lein M; Sánchez Fernández I; Jackson M; Abend NS; Arya R; Brenton JN; Carpenter JL; Chapman KE; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Kapur K; Mikati MA; Peariso K; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    JAMA Neurol; 2018 Apr; 75(4):410-418. PubMed ID: 29356811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.
    Kravljanac R; Djuric M; Jankovic B; Pekmezovic T
    Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory generalised convulsive status epilepticus : a guide to treatment.
    Kälviäinen R; Eriksson K; Parviainen I
    CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.
    Esaian D; Joset D; Lazarovits C; Dugan PC; Fridman D
    Ann Pharmacother; 2013 Nov; 47(11):1569-76. PubMed ID: 24259603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine for Refractory Status Epilepticus: A Systematic Review.
    Rosati A; De Masi S; Guerrini R
    CNS Drugs; 2018 Nov; 32(11):997-1009. PubMed ID: 30232735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine for the treatment of refractory status epilepticus.
    Fang Y; Wang X
    Seizure; 2015 Aug; 30():14-20. PubMed ID: 26216679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
    İşgüder R; Güzel O; Ceylan G; Yılmaz Ü; Ağın H
    J Child Neurol; 2016 Aug; 31(9):1120-6. PubMed ID: 27080042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated identification and quality measurement for pediatric convulsive status epilepticus.
    Hess-Homeier DL; Parikh K; Basma N; Vella AE; Grinspan ZM
    Epilepsia; 2021 Feb; 62(2):337-346. PubMed ID: 33341928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Choice and administration sequence of antiepileptic agents for status epilepticus and frequent seizures in children].
    Hamano S; Sugiyama N; Tanaka M; Yamashita S; Yoshinari S; Minamitani M; Hayakawa M; Kikuchi K; Eto Y
    No To Hattatsu; 2005 Sep; 37(5):395-9. PubMed ID: 16164245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the treatment of convulsive status epilepticus.
    Zaccara G; Giannasi G; Oggioni R; Rosati E; Tramacere L; Palumbo P;
    Seizure; 2017 Apr; 47():17-24. PubMed ID: 28282553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.